Free Trial

Denali Therapeutics (DNLI) News Today

Denali Therapeutics logo
$15.99 -0.45 (-2.74%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$16.01 +0.02 (+0.13%)
As of 05/5/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Denali Therapeutics Inc. stock logo
Denali Therapeutics (DNLI) Projected to Post Quarterly Earnings on Tuesday
Denali Therapeutics (NASDAQ:DNLI) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-denali-therapeutics-inc-stock/)
Denali Therapeutics Inc. stock logo
Susquehanna Fundamental Investments LLC Acquires New Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Susquehanna Fundamental Investments LLC bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 192,563 shares of the company's stock, valued at approximately $3,
Denali Therapeutics Inc. stock logo
Price T Rowe Associates Inc. MD Grows Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Price T Rowe Associates Inc. MD lifted its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 6.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,058,615 shares of the company's stoc
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Invesco Ltd.
Invesco Ltd. cut its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 41.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,478 shares of the company's stock after selling
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Upgraded to Strong-Buy at William Blair
William Blair raised Denali Therapeutics to a "strong-buy" rating in a report on Thursday.
Denali Therapeutics Inc. stock logo
Barclays PLC Has $5.67 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Barclays PLC grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 8.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 278,067 shares of the company's stock after purchasing an additional 22
Denali Therapeutics Inc. stock logo
24,820 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Bought by Walleye Capital LLC
Walleye Capital LLC bought a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 24,820 shares of the company's stock, valued at approxi
Denali Therapeutics Inc. stock logo
Guggenheim Capital LLC Acquires 27,518 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Guggenheim Capital LLC lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 133.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,131 shares of the c
Denali Therapeutics Inc. stock logo
60,000 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Bought by Diadema Partners LP
Diadema Partners LP purchased a new stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 60,000 shares of the company's stock, valued at appro
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Stock Price Up 6.6% - Time to Buy?
Denali Therapeutics (NASDAQ:DNLI) Stock Price Up 6.6% - Here's What Happened
Denali Therapeutics Inc. stock logo
Capital Research Global Investors Decreases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Capital Research Global Investors lowered its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 30.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,477,211 shares of the company's stock after selling 2,431,903 shares during the quarter. Ca
Denali Therapeutics Inc. stock logo
Marshall Wace LLP Sells 178,404 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Marshall Wace LLP lessened its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 9.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,788,737 shares of the company's stock after selling 178,404 shares during the period. Marshall Wa
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) have received a consensus rating of "Buy" from the seventeen research firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, fifteen have assigned a b
Denali Therapeutics Inc. stock logo
Fmr LLC Buys 188,368 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Fmr LLC lifted its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,019,746 shares of the company's stock after purchasing an additional 188,368 shares during the quarte
Denali Therapeutics Inc. stock logo
Geode Capital Management LLC Trims Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Geode Capital Management LLC lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,935,283 shares of the company's stock afte
Denali Therapeutics Inc. stock logo
Cantor Fitzgerald Analysts Lower Earnings Estimates for DNLI
Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings estimates for Denali Therapeutics in a research report issued to clients and investors on Thursday, April 10th. Cantor Fitzgerald analyst J. Schimmer now forecasts that
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Upgraded by Cantor Fitzgerald
Cantor Fitzgerald raised Denali Therapeutics from a "neutral" rating to an "overweight" rating in a research report on Thursday.
Denali Therapeutics Inc. stock logo
Trexquant Investment LP Buys 36,122 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Trexquant Investment LP increased its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 147.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,656 shares of the company's stock after p
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Reaches New 1-Year Low - Here's What Happened
Denali Therapeutics (NASDAQ:DNLI) Sets New 52-Week Low - Time to Sell?
Denali Therapeutics Inc. stock logo
ADAR1 Capital Management LLC Reduces Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
ADAR1 Capital Management LLC decreased its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 56.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,826 shares of the company's st
Denali Therapeutics Inc. stock logo
Raymond James Financial Inc. Buys New Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Raymond James Financial Inc. purchased a new position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 26,143 shares of the company's stock, valued a
Denali Therapeutics Inc. stock logo
1,065,608 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Acquired by Norges Bank
Norges Bank bought a new stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,065,608 shares of the company's stock, valued at approximately $21,717,00
Denali Therapeutics Inc. stock logo
Schroder Investment Management Group Has $5.02 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Schroder Investment Management Group increased its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 94.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 247,800 shares of the company
Denali Therapeutics Inc. stock logo
Vanguard Group Inc. Increases Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Vanguard Group Inc. grew its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 7.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,021,230 shares of the company's stock after
Denali Therapeutics Inc. stock logo
Cinctive Capital Management LP Lowers Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
Cinctive Capital Management LP cut its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 12.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 130,445 shares of the company's stock after selling 18,649 shares duri
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Stock Position Raised by Alliancebernstein L.P.
Alliancebernstein L.P. grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,315,642 shares of the company's stock after purchasing an ad
Denali Therapeutics Inc. stock logo
KLP Kapitalforvaltning AS Makes New Investment in Denali Therapeutics Inc. (NASDAQ:DNLI)
KLP Kapitalforvaltning AS purchased a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 26,100 share
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Trading 4.1% Higher - Still a Buy?
Denali Therapeutics (NASDAQ:DNLI) Stock Price Up 4.1% - Here's Why
Denali Therapeutics Inc. stock logo
Groupama Asset Managment Raises Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI)
Groupama Asset Managment raised its stake in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 41.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 110,207 shares of the company's stock after acquiring an additio
Denali Therapeutics Inc. stock logo
Wellington Management Group LLP Trims Stake in Denali Therapeutics Inc. (NASDAQ:DNLI)
Wellington Management Group LLP lessened its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 8.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,847,951 shares of the company's stock after
Denali Therapeutics Inc. stock logo
American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI)
American Century Companies Inc. increased its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 480,529 shares of the com
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Sets New 12-Month Low - Should You Sell?
Denali Therapeutics (NASDAQ:DNLI) Reaches New 12-Month Low - Should You Sell?
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Trading Down 7.7% - Here's Why
Denali Therapeutics (NASDAQ:DNLI) Shares Down 7.7% - Should You Sell?
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Artisan Partners Limited Partnership
Artisan Partners Limited Partnership reduced its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,054,523 shares of the company's stock after selling 36,495 s
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Sold by Thrivent Financial for Lutherans
Thrivent Financial for Lutherans lowered its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 33.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 92,972 shares of the company's stock after selling 45,
Denali Therapeutics Inc. stock logo
Segall Bryant & Hamill LLC Invests $5.89 Million in Denali Therapeutics Inc. (NASDAQ:DNLI)
Segall Bryant & Hamill LLC bought a new stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 289,075 shares of the company's stock, valued at approximately
Denali Therapeutics Becomes Oversold (DNLI)
Denali Therapeutics Inc. stock logo
Denali Therapeutics (NASDAQ:DNLI) Sets New 1-Year Low - Here's Why
Denali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low - Here's What Happened
Denali Therapeutics Inc. stock logo
Pier Capital LLC Acquires 164,237 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
Pier Capital LLC lifted its holdings in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 97.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 332,319 shares of the company's stock after purchasing an addition
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Given Average Rating of "Moderate Buy" by Brokerages
Denali Therapeutics Inc. (NASDAQ:DNLI - Get Free Report) has received an average rating of "Moderate Buy" from the eighteen brokerages that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, fifteen have given a buy recomm
Denali Therapeutics Inc. stock logo
Fox Run Management L.L.C. Makes New $788,000 Investment in Denali Therapeutics Inc. (NASDAQ:DNLI)
Fox Run Management L.L.C. purchased a new position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 38,668 shares of the company's stock, valued at
Denali Therapeutics Inc. stock logo
Proficio Capital Partners LLC Makes New $514,000 Investment in Denali Therapeutics Inc. (NASDAQ:DNLI)
Proficio Capital Partners LLC purchased a new position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,210 shares of the compan
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Purchased by Intech Investment Management LLC
Intech Investment Management LLC boosted its position in Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 60.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,401 shares of the company's stock after acquiring
Denali Therapeutics Inc. stock logo
Denali Therapeutics Inc. (NASDAQ:DNLI) Holdings Boosted by Yiheng Capital Management L.P.
Yiheng Capital Management L.P. lifted its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) by 16.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 700,098 shares of the company's stock after purchasin
Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.

DNLI Media Mentions By Week

DNLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DNLI
News Sentiment

1.25

0.72

Average
Medical
News Sentiment

DNLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DNLI Articles
This Week

4

6

DNLI Articles
Average Week

Get Denali Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNLI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:DNLI) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners